You are here

Offerings On Manhattan Street Capital

New and Updated Offerings live on Manhattan Street Capital ERC Homebuilders Investors in ERC Homebuilders receive an 8% per annum dividend, paid monthly from the date of investment with the potential for appreciation in share price over time. Leveraging more than 100 combined years in real estate...
I am pleased to announce two new offerings on Manhattan Street Capital, TransCode Therapeutics and GolfSuites 1, and to update you on the ongoing offerings on our ...
My update to you on the latest changes in the live offerings on Manhattan Street Capital; InSitu Biologics - AnestaGel™. Pausing soon*. Eliminate the need for addictive...
InSitu Biologics - AnestaGel™ -  Eliminate the need for addictive opiates for pain management after surgery. AnestaGel™ is a non-opioid pain relief drug based on...
If you are in the San Diego area: You’re invited to my seminar on July 24, “How to Succeed Raising Capital via a Regulation Compliant ICO/STO.” I’ll speak to all key...
Genprex is raising capital through their IPO to progress Clinical trials for their Gene Therapy lung cancer treatment. Genprex has developed Oncoprex, a unique medicine...
Muscle Maker, Inc. Reg A+ IPO Raising $20 mill at $51 mill pre-money valuation, plans to List on the NYSE in January. Underwritten by Tripoint. Muscle Maker Grill is a...
BitPlus - Mining Bitcoin and other cryptocurrencies with ultra-low cost and high efficiency, live to investors. The people who made the most money in the gold rush were...
Genprex (S-1 IPO) expects to list on the NASDAQ on Friday March 16th - two days left. Their Oncoprex medicine delivers DNA to lung cancer cells via custom nanoparticles...